文献速递心律失常心力衰竭与心肌病

设备检测的亚临床房颤进展与心力衰竭风险

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究基于ASSERT试验中415例植入起搏器或除颤器、无临床房颤的≥65岁高血压患者,评估首年最长亚临床房颤(SCAF)发作>6分钟但≤24小时者,后续进展为SCAF>24小时或临床房颤与心衰住院的关系。平均随访2年,15.7%患者出现SCAF进展,进展者心衰住院率8.9%/年,未进展者2.5%/年,多变量校正后SCAF进展与心衰住院独立相关(HR 4.58)。

要点

  • SCAF进展定义为发作时长从>6分钟但≤24小时发展为>24小时或临床房颤。
  • SCAF进展者心衰住院风险显著增高,多变量校正HR为4.58。
  • 排除既往心衰病史后,SCAF进展与心衰住院的关联仍显著。

核心结论

  • 在植入起搏器或除颤器的患者中,SCAF进展与心衰住院强烈相关。

研究设计与样本

  • ASSERT试验中415例≥65岁、有高血压史、无临床房颤且植入起搏器或除颤器的患者,首年最长SCAF发作>6分钟但≤24小时。
  • 采用时间依赖Cox模型评估后续SCAF>24小时或临床房颤与心衰住院的关系,平均随访2年。

主要发现

  • 平均随访2年,65例(15.7%)进展为SCAF>24小时或临床房颤,年发生率8.8%。
  • SCAF进展者心衰住院率8.9%/年,未进展者2.5%/年。
  • 多变量校正后SCAF进展与心衰住院独立相关(HR 4.58;95%CI 1.64-12.80;p=0.004)。
  • 排除既往心衰病史后HR 7.06(95%CI 1.82-27.30;p=0.005);仅以SCAF>24小时定义进展时HR 3.68(95%CI 1.27-10.70;p=0.016)。
  • 年龄较大、体重指数较高、首年内SCAF持续时间较长是SCAF进展的独立预测因素。

临床怎么用

  • 对植入起搏器或除颤器且检出短阵SCAF的老年高血压患者,应关注SCAF进展并及时评估心衰风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term continuous monitoring detects short-lasting, subclinical atrial fibrillation (SCAF) in approximately one-third of older individuals with cardiovascular conditions. The relationship between SCAF, its progression, and the development of heart failure (HF) is unclear. OBJECTIVES: This study examined the relationship between progression from shorter to longer SCAF episodes and HF hospitalization. METHODS: Subjects in ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial) were ≥65 years old, had history of hypertension, no prior clinical AF, and an implanted pacemaker or defibrillator. We examined patients whose longest SCAF episode during the first year after enrollment was >6 min but ≤24 h (n = 415). Using time-dependent Cox models, we evaluated the relationship between subsequent development of SCAF >24 h or clinical AF and HF hospitalization. RESULTS: Over a mean follow-up of 2 years, 65 patients (15.7%) progressed to having SCAF episodes >24 h or clinical AF (incidence 8.8% per year). Older age, greater body mass index, and longer SCAF duration within the first year were independent predictors of SCAF progression. The rate of HF hospitalization among patients with SCAF progression was 8.9% per year compared with 2.5% per year for those without progression. After multivariable adjustment, SCAF progression was independently associated with HF hospitalization (hazard ratio [HR]: 4.58; 95% confidence interval [CI]: 1.64 to 12.80; p = 0.004). Similar results were observed when we excluded patients with prior history of HF (HR: 7.06; 95% CI: 1.82 to 27.30; p = 0.005) or when SCAF progression was defined as development of SCAF >24 h alone (HR: 3.68; 95% CI: 1.27 to 10.70; p = 0.016). CONCLUSIONS: In patients with a pacemaker or defibrillator, SCAF progression was strongly associated with HF hospitalization.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wong JA, Conen D, Van Gelder IC, et al. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure. J Am Coll Cardiol. 2018. PMID: 29880119. doi:10.1016/j.jacc.2018.03.519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。